| Pierce Hua, | |
|
1420 E Roseville Pkwy Ste 130, Roseville, CA 95661-3081 | |
| (916) 740-1600 | |
| (916) 740-1601 |
| Full Name | Pierce Hua |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1420 E Roseville Pkwy Ste 130, Roseville, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700361011 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH235825 (Massachusetts) | Secondary |
| 183500000X | Pharmacist | 77921 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pierce Hua, 1420 E Roseville Pkwy Ste 130, Roseville, CA 95661-3081 Ph: (916) 740-1600 | Pierce Hua, 1420 E Roseville Pkwy Ste 130, Roseville, CA 95661-3081 Ph: (916) 740-1600 |
News Archive
Care Improvement Plus, operator of one of the largest special needs plans in Texas, is standing by its commitment to serve chronically ill and underserved Medicare beneficiaries with the release of its 2011 Medicare health plan benefits in preparation for the upcoming Medicare annual election period, which begins November 15th.
Newly diagnosed cancer patients frequently face hurdles in obtaining an appointment for care with an oncologist, according to new research from the Perelman School of Medicine at the University of Pennnsylvania that will be presented Saturday, June 4 at the 2011 annual meeting of American Society of Clinical Oncology.
Sweden's MPA has today granted the first regulatory approval in the world for FOSRENOL (lanthanum carbonate), a non-calcium, non-aluminium phosphate binding medicine developed to control phosphate levels in renal dialysis patients. Sweden will now become the Reference Member State in the EU Mutual Recognition Procedure for FOSRENOL, and this is the first step in securing marketing approval throughout Europe. A submission has also been made by Shire to gain marketing approval for FOSRENOL in the United States.
A team of researchers from the Massachusetts General Hospital Center for Engineering in Medicine has developed a novel approach that dramatically simplifies the evaluation of the liver's drug-metabolizing activity and the potential toxic effects of the products of that activity on other organs.
› Verified 1 days ago
Lynn Tuyet Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 | |
Carol Lynn Schulz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4184 | |
Jessica Ng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-474-6555 | |
Dr. Mina Eskandar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1298 Antelope Creek Dr, #521, Roseville, CA 95678 Phone: 518-506-2513 | |
Madison Le, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9280 Sierra College Blvd, Roseville, CA 95661 Phone: 916-772-5313 | |
Mr. Joseph Chadwick Jacobs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 446 Roseville Sq, Roseville, CA 95678 Phone: 916-784-1590 Fax: 916-784-1728 | |
Saimah Arshad, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Riverside Ave, Roseville, CA 95678 Phone: 916-486-5256 |